Reach Us. +44 1223 790975
Citations Report - Journal of Alzheimers Disease and Parkinsonism | 3

ºÚÁÏÍø

ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
ºÚÁÏÍø

Like us on:

organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 3123

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Articles published in Journal of Alzheimers Disease & Parkinsonism have been cited by esteemed scholars and scientists all around the world. Journal of Alzheimers Disease & Parkinsonism has got h-index 25, which means every article in Journal of Alzheimers Disease & Parkinsonism has got 25 average citations.

Following are the list of articles that have cited the articles published in Journal of Alzheimers Disease & Parkinsonism.

  2023 2022 2021 2020 2019 2018 2017 2016

Total published articles

26 33 60 35 45 44 107 89

Conference proceedings

0 33 0 0 82 213 118 158

Citations received as per Google Scholar, other indexing platforms and portals

123 389 489 425 374 263 237 253
Journal total citations count 3123
Journal impact factor 2.04
Journal 5 years impact factor 3.14
Journal cite score 10.01
Journal h-index 25
Journal h-index since 2019 22
image

Nanotoxicity and Risk Assessment

  | |
image

Modulation of the microbiota-gut-brain axis by bioactive food, prebiotics, and probiotics decelerates the course of Alzheimer's disease

  | |
image

Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease

  | |
image

Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer’s Disease in Mice

  | |
image

Roles of Gut Microbiota in Pathogenesis of Alzheimer’s Disease and Therapeutic Effects of Chinese Medicine

  | |
image

Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine

  | |
image

Crosstalk between Gut and Brain in Alzheimer’s Disease: The Role of Gut Microbiota Modulation Strategies

  | |
image

Dysbiosis and Alzheimer’s Disease: A Role for Chronic Stress?

  | |
image

Alternative Anti-Infective / Anti-Inflammatory Therapeutic Options for Fighting Alzheimer’s Disease

  | |
image

The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?

  | |
image

The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?

  | |
image

Facilitation of Gastrointestinal (GI) Tract Microbiome-Derived Lipopolysaccharide (LPS) Entry Into Human Neurons by Amyloid Beta-42 (A?42) Peptide

  | |
image

Cell surface amyloid proteins of microorganisms: structure, properties and significance in medicine

  | |
image

The role of the gut microbiome in mediating neurotoxic outcomes to PCB exposure

  | |
image

A Gut Feeling: The Importance of the Intestinal Microbiota in Psychiatric Disorders

  | |
image

Age-related cerebral small vessel disease and inflammaging

  | |
image

Functional amyloids: interrelationship with other amyloids and therapeutic assessment to treat neurodegenerative diseases

  | |
image

Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer’s Disease

  | |
image

Down-Regulation of Essential Synaptic Components by GI-Tract Microbiome-Derived Lipopolysaccharide (LPS) in LPS-Treated Human Neuronal-Glial (HNG) Cells in Primary Culture: Relevance to Alzheimer’s Disease (AD)

  | |
image

Accelerated Amyloid Beta Pathogenesis by Bacterial Amyloid FapC

  | |

Contact Us

Agri and Aquaculture Journals

Dr. Krish

agriaquaculture@omicsonline.com

+1-702-714-7001Extn: 9040

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

chemistryjournals@omicsonline.com

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

clinicaljournals@omicsonline.com

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

engineeringjournals@omicsonline.com

1-702-714-7001Extn: 9042

General Science

Andrea Jason

generalscience@omicsonline.com

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

geneticsmolbio@omicsonline.com

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immunomicrobiol@omicsonline.com

1-702-714-7001Extn: 9014

Nursing & Health Care Journals

Stephanie Skinner

nursinghealthcare@omicsonline.com

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

medicaljournals@omicsonline.com

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuropsychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

pharmajournals@omicsonline.com

1-702-714-7001Extn: 9007

 
© 2008- 2024 - ºÚÁÏÍø. Best viewed in | |